Literature DB >> 24716563

Biliary dyskinesia in pediatrics.

Arvind Srinath, Miguel Saps, Klaus Bielefeldt.   

Abstract

Biliary dyskinesia (BD) is a diagnosis that is being made increasingly in children. It is defined by abdominal pain thought to be biliary in nature based on location and character; a completely normal gallbladder on imaging tests, typically ultrasound; and decreased gallbladder contraction in response to a pharmacological stimulus. Unlike other functional gastrointestinal disorders (FGIDs) that are treated with medications, behavioral therapy, and/or dietary modification, current clinical practice has accepted cholecystectomy as the treatment of choice for BD, which now accounts for up to 50% of cholecystectomies in children. Although well-designed trials are missing, accumulating evidence argues against such an approach. First, BD is by definition a benign disorder without risk of truly relevant complications. Second, despite reportedly high rates of satisfaction with postoperative outcomes, most children continue to experience symptoms. Lastly, limited long-term studies have demonstrated comparable benefit of operative and conservative therapy. To summarize, BD should be seen as a more localized manifestation of functional abdominal pain, which may improve over time independent of the type of therapy chosen. Despite the widespread adoption of minimally invasive surgery in pediatrics, a different risk-benefit ratio favors conservative treatment for this benign disorder. Copyright 2014, SLACK Incorporated.

Entities:  

Mesh:

Year:  2014        PMID: 24716563     DOI: 10.3928/00904481-20140325-09

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  2 in total

1.  Decision-making patterns in managing children with suspected biliary dyskinesia.

Authors:  Warapan Nakayuenyongsuk; Hassan Choudry; Karla Au Yeung; Wikrom Karnsakul
Journal:  World J Clin Pediatr       Date:  2017-05-08

2.  Chronic cholecystitis in the pediatric population: an underappreciated disease process.

Authors:  Brian P Blackwood; Julia Grabowski
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.